These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9315139)
1. A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas. Hamada Y; Iwaki T; Fukui M; Tateishi J Surg Neurol; 1997 Oct; 48(4):395-400. PubMed ID: 9315139 [TBL] [Abstract][Full Text] [Related]
2. Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas. Saito K; Kato M; Susaki N; Nagatani T; Nagasaka T; Yoshida J Clin Neuropathol; 2003; 22(1):30-4. PubMed ID: 12617191 [TBL] [Abstract][Full Text] [Related]
3. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091 [TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom. Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104 [TBL] [Abstract][Full Text] [Related]
5. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2. Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213 [TBL] [Abstract][Full Text] [Related]
6. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530 [TBL] [Abstract][Full Text] [Related]
9. Management of multiple tumors in neurofibromatosis type 2 patients. Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis 2 in the pediatric age group. Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853 [TBL] [Abstract][Full Text] [Related]
11. Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas. Tamura R; Morimoto Y; Sato M; Kuranari Y; Oishi Y; Kosugi K; Yoshida K; Toda M J Neurooncol; 2020 Jan; 146(2):265-273. PubMed ID: 31897926 [TBL] [Abstract][Full Text] [Related]
12. Unusual case of multiple cellular and malignant schwannomas of the cranial and spinal nerves. Suresh TN; Mahadevan A; Chandrashekhar Sagar B; Santosh V; Yasha TC; Shankar SK Clin Neuropathol; 2003; 22(1):23-9. PubMed ID: 12617190 [TBL] [Abstract][Full Text] [Related]
13. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene. Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935 [TBL] [Abstract][Full Text] [Related]